Page 151 - Read Online

surgery. Psychosom Med 2014;[Epub ahead of print]. 33. Kannan S, Balakrishnan B, Muzik O, Romero R, Chugani D. Positron
15. Hovens IB, Schoemaker RG, van der Zee EA, Absalom AR, emission tomography imaging of neuroinflammation. J Child Neurol
Heineman E, van Leeuwen BL. Postoperative cognitive dysfunction: 2009;24:1190‑9.
involvement of neuroinflammation and neuronal functioning. Brain 34. Cagnin A, Taylor‑Robinson SD, Forton DM, Banati RB. In vivo
Behav Immun 2014;38:202‑10. imaging of cerebral “peripheral benzodiazepine binding sites” in
16. Barrientos RM, Hein AM, Frank MG, Watkins LR, Maier SF. patients with hepatic encephalopathy. Gut 2006;55:547‑53.
Intracisternal interleukin‑1 receptor antagonist prevents postoperative 35. Dennis CV, Sheahan PJ, Graeber MB, Sheedy DL, Kril JJ,
cognitive decline and neuroinflammatory response in aged rats. Sutherland GT. Microglial proliferation in the brain of chronic
J Neurosci 2012;32:14641‑8. alcoholics with hepatic encephalopathy. Metab Brain Dis
17. Felipo V. Hepatic encephalopathy: effects of liver failure on brain 2014;29:1027‑39.
function. Nat Rev Neurosci 2013;14:851‑8. 36. Zemtsova I, Gorg B, Keitel V, Bidmon HJ, Schror K, Haussinger D.
18. Leevy CB, Phillips JA. Hospitalizations during the use of rifaximin Microglia activation in hepatic encephalopathy in rats and humans.
versus lactulose for the treatment of hepatic encephalopathy. Dig Hepatology 2011;54:204‑15.
Dis Sci 2007;52:737‑41. 37. Vivithanaporn P, Maingat F, Lin LT, Na H, Richardson CD,
19. Conn HO, Leevy CM, Vlahcevic ZR, Rodgers JB, Maddrey WC, Agrawal B, Cohen EA, Jhamandas JH, Power C. Hepatitis C virus
Seeff L, Levy LL. Comparison of lactulose and neomycin in the core protein induces neuroimmune activation and potentiates
treatment of chronic portal‑systemic encephalopathy. A double human immunodeficiency virus‑1 neurotoxicity. PLoS One
blind controlled trial. Gastroenterology 1977;72:573‑83. 2010;5:e12856.
20. Weissenborn K, Giewekemeyer K, Heidenreich S, Bokemeyer M, 38. Grover VP, Pavese N, Koh SB, Wylezinska M, Saxby BK, Gerhard A,
Berding G, Ahl B. Attention, memory, and cognitive function in Forton DM, Brooks DJ, Thomas HC, Taylor‑Robinson SD. Cerebral
hepatic encephalopathy. Metab Brain Dis 2005;20:359‑67. microglial activation in patients with hepatitis C: in vivo evidence
21. Amodio P, Schiff S, Del Piccolo F, Mapelli D, Gatta A, Umilta C. of neuroinflammation. J Viral Hepat 2012;19:e89‑96.
Attention dysfunction in cirrhotic patients: an inquiry on the role 39. Bokemeyer M, Ding XQ, Goldbecker A, Raab P, Heeren M,
of executive control, attention orienting and focusing. Metab Brain Arvanitis D, Tillmann HL, Lanfermann H, Weissenborn K.
Dis 2005;20:115‑27. Evidence for neuroinflammation and neuroprotection in HCV
22. Felipo V, Ordono JF, Urios A, El Mlili N, Gimenez‑Garzo C, infection‑associated encephalopathy. Gut 2011;60:370‑7.
Aguado C, Gonzalez‑Lopez O, Giner‑Duran R, Serra MA, 40. Cauli O, Rodrigo R, Piedrafita B, Boix J, Felipo V. Inflammation
Wassel A, Rodrigo JM, Salazar J, Montoliu C. Patients with and hepatic encephalopathy: ibuprofen restores learning ability in
minimal hepatic encephalopathy show impaired mismatch negativity rats with portacaval shunts. Hepatology 2007;46:514‑9.
correlating with reduced performance in attention tests. Hepatology 41. Butterworth RF, Norenberg MD, Felipo V, Ferenci P, Albrecht J,
2012;55:530‑9. Blei AT, Members of the ISHEN Commission on Experimental
23. Bajaj JS. Minimal hepatic encephalopathy matters in daily life. Models of HE. Experimental models of hepatic encephalopathy:
World J Gastroenterol 2008;14:3609‑15. ISHEN guidelines. Liver Int 2009;29:783‑8.
24. Wein C, Koch H, Popp B, Oehler G, Schauder P. Minimal hepatic 42. Erceg S, Monfort P, Hernandez‑Viadel M, Rodrigo R, Montoliu C,
encephalopathy impairs fitness to drive. Hepatology 2004;39:739‑45. Felipo V. Oral administration of sildenafil restores learning ability in
25. Felipo V, Urios A, Valero P, Sanchez M, Serra MA, Pareja I, rats with hyperammonemia and with portacaval shunts. Hepatology
Rodriguez F, Gimenez‑Garzo C, Sanmartin J, Montoliu C. Serum 2005;41:299‑306.
nitrotyrosine and psychometric tests as indicators of impaired fitness 43. Cauli O, Rodrigo R, Piedrafita B, Llansola M, Mansouri MT, Felipo V.
to drive in cirrhotic patients with minimal hepatic encephalopathy. Neuroinflammation contributes to hypokinesia in rats with hepatic
Liver Int 2013;33:1478‑89. encephalopathy: ibuprofen restores its motor activity. J Neurosci
26. Romero‑Gomez M, Boza F, Garcia‑Valdecasas MS, Garcia E, Res 2009;87:1369‑74.
Aguilar‑Reina J. Subclinical hepatic encephalopathy predicts the 44. Cauli O, Llansola M, Erceg S, Felipo V. Hypolocomotion in rats with
development of overt hepatic encephalopathy. Am J Gastroenterol chronic liver failure is due to increased glutamate and activation of
2001;96:2718‑23. metabotropic glutamate receptors in substantia nigra. J Hepatol
27. Roman E, Cordoba J, Torrens M, Torras X, Villanueva C, Vargas V, 2006;45:654‑61.
Guarner C, Soriano G. Minimal hepatic encephalopathy is 45. Rodrigo R, Cauli O, Gomez‑Pinedo U, Agusti A, Hernandez‑Rabaza V,
associated with falls. Am J Gastroenterol 2011;106:476‑82. Garcia‑Verdugo JM, Felipo V. Hyperammonemia induces
28. Stepanova M, Mishra A, Venkatesan C, Younossi ZM. In‑hospital neuroinflammation that contributes to cognitive impairment in rats
mortality and economic burden associated with hepatic with hepatic encephalopathy. Gastroenterology 2010;139:675‑84.
encephalopathy in the United States from 2005 to 2009. Clin 46. Hermenegildo C, Montoliu C, Llansola M, Munoz MD, Gaztelu JM,
Gastroenterol Hepatol 2012;10:1034‑41. Minana MD, Felipo V. Chronic hyperammonemia impairs the
29. Bajaj JS, Pinkerton SD, Sanyal AJ, Heuman DM. Diagnosis glutamate‑nitric oxide‑cyclic GMP pathway in cerebellar neurons
and treatment of minimal hepatic encephalopathy to prevent in culture and in the rat in vivo. Eur J Neurosci 1998;10:3201‑9.
motor vehicle accidents: a cost‑effectiveness analysis. Hepatology 47. Aguilar MA, Minarro J, Felipo V. Chronic moderate
2012;55:1164‑71. hyperammonemia impairs active and passive avoidance behavior
30. Montoliu C, Piedrafita B, Serra MA, del Olmo JA, Urios A, and conditional discrimination learning in rats. Exp Neurol
Rodrigo JM, Felipo V. IL‑6 and IL‑18 in blood may discriminate 2000;161:704‑13.
cirrhotic patients with and without minimal hepatic encephalopathy. 48. Cauli O, Rodrigo R, Llansola M, Montoliu C, Monfort P, Piedrafita B,
J Clin Gastroenterol 2009;43:272‑9. El Mlili N, Boix J, Agusti A, Felipo V. Glutamatergic and gabaergic
31. Shawcross DL, Davies NA, Williams R, Jalan R. Systemic neurotransmission and neuronal circuits in hepatic encephalopathy.
inflammatory response exacerbates the neuropsychological Metab Brain Dis 2009;24:69‑80.
effects of induced hyperammonemia in cirrhosis. J Hepatol 49. Monfort P, Cauli O, Montoliu C, Rodrigo R, Llansola M, Piedrafita B,
2004;40:247‑54. El Mlili N, Boix J, Agusti A, Felipo V. Mechanisms of cognitive
32. Felipo V, Urios A, Montesinos E, Molina I, Garcia‑Torres ML, alterations in hyperammonemia and hepatic encephalopathy:
Civera M, Olmo JA, Ortega J, Martinez‑Valls J, Serra MA, therapeutical implications. Neurochem Int 2009;55:106‑12.
Cassinello N, Wassel A, Jorda E, Montoliu C. Contribution 50. Rangroo Thrane V, Thrane AS, Wang F, Cotrina ML, Smith NA,
of hyperammonemia and inflammatory factors to cognitive Chen M, Xu Q, Kang N, Fujita T, Nagelhus EA, Nedergaard M.
impairment in minimal hepatic encephalopathy. Metab Brain Dis Ammonia triggers neuronal disinhibition and seizures by impairing
2012;27:51‑8. astrocyte potassium buffering. Nat Med 2013;19:1643‑8.

142 Neuroimmunol Neuroinflammation | Volume 2 | Issue 3 | July 15, 2015 Neuroimmunol Neuroinflammation | Volume 2 | Issue 3 | July 15, 2015 143